462 related articles for article (PubMed ID: 31520800)
1. Antiphospholipid antibodies and the risk of thrombocytopenia in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
Chock YP; Moulinet T; Dufrost V; Erkan D; Wahl D; Zuily S
Autoimmun Rev; 2019 Nov; 18(11):102395. PubMed ID: 31520800
[TBL] [Abstract][Full Text] [Related]
2. Antiphospholipid antibodies and the risk of autoimmune hemolytic anemia in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
Bernardoff I; Picq A; Loiseau P; Foret T; Dufrost V; Moulinet T; Unlu O; Erkan D; Wahl D; Zuily S
Autoimmun Rev; 2022 Jan; 21(1):102913. PubMed ID: 34371159
[TBL] [Abstract][Full Text] [Related]
3. Antiphospholipid antibodies can identify lupus patients at risk of pulmonary hypertension: A systematic review and meta-analysis.
Zuily S; Domingues V; Suty-Selton C; Eschwège V; Bertoletti L; Chaouat A; Chabot F; Regnault V; Horn EM; Erkan D; Wahl D
Autoimmun Rev; 2017 Jun; 16(6):576-586. PubMed ID: 28411166
[TBL] [Abstract][Full Text] [Related]
4. Risk of livedo with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
Loiseau P; Foret T; DeFilippis EM; Risse J; Etienne AD; Dufrost V; Moulinet T; Erkan D; Devilliers H; Wahl D; Zuily S
Lupus; 2022 Nov; 31(13):1595-1605. PubMed ID: 36112747
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of acute and chronic microvascular renal lesions associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
Domingues V; Chock EY; Dufrost V; Risse J; Seshan SV; Barbhaiya M; Sartelet H; Erkan D; Wahl D; Zuily S
Autoimmun Rev; 2022 Oct; 21(10):103158. PubMed ID: 35907609
[TBL] [Abstract][Full Text] [Related]
6. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.
Frodlund M; Vikerfors A; Grosso G; Skogh T; Wetterö J; Elvin K; Gunnarsson I; Kastbom A; Dahlström Ö; Rönnelid J; Svenungsson E; Sjöwall C
Clin Exp Immunol; 2018 Oct; 194(1):27-38. PubMed ID: 30208508
[TBL] [Abstract][Full Text] [Related]
9. Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: meta-analysis of echocardiographic studies.
Zuily S; Regnault V; Selton-Suty C; Eschwège V; Bruntz JF; Bode-Dotto E; De Maistre E; Dotto P; Perret-Guillaume C; Lecompte T; Wahl D
Circulation; 2011 Jul; 124(2):215-24. PubMed ID: 21690492
[TBL] [Abstract][Full Text] [Related]
10. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
[TBL] [Abstract][Full Text] [Related]
11. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
[TBL] [Abstract][Full Text] [Related]
12. Do all antiphospholipid antibodies confer the same risk for major organ involvement in systemic lupus erythematosus patients?
Riancho-Zarrabeitia L; Martínez-Taboada VM; Rúa-Figueroa I; Alonso F; Galindo-Izquierdo M; Ovalles J; Olivé-Marqués A; Mena Vázquez N; Calvo-Alén J; Menor Almagro R; Tomero Muriel E; Uriarte Isacelaya E; Boteanu A; Andres M; Freire González M; Santos Soler G; Ruiz-Lucea ME; Ibáñez-Barceló M; Castellví I; Galisteo C; Quevedo Vila V; Raya E; Narváez J; Expósito L; Hernández Beriaín JA; Horcada L; Aurrecoechea E; Pego Reigosa JM
Clin Exp Rheumatol; 2021; 39(3):555-563. PubMed ID: 32828148
[TBL] [Abstract][Full Text] [Related]
13. Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL).
Savelli SL; Roubey RAS; Kitzmiller KJ; Zhou D; Nagaraja HN; Mulvihill E; Barbar-Smiley F; Ardoin SP; Wu YL; Yu CY
Front Immunol; 2019; 10():885. PubMed ID: 31134052
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of antibodies to anionic phospholipids in patients with the primary antiphospholipid syndrome, systemic lupus erythematosus and their relatives and spouses.
Radway-Bright EL; Ravirajan CT; Isenberg DA
Rheumatology (Oxford); 2000 Apr; 39(4):427-31. PubMed ID: 10817777
[TBL] [Abstract][Full Text] [Related]
15. Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis.
Reynaud Q; Lega JC; Mismetti P; Chapelle C; Wahl D; Cathébras P; Laporte S
Autoimmun Rev; 2014 Jun; 13(6):595-608. PubMed ID: 24418303
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus.
Cabral AR; Cabiedes J; Alarcón-Segovia D
Lupus; 2004; 13(3):182-7. PubMed ID: 15119547
[TBL] [Abstract][Full Text] [Related]
17. [Cardiac abnormalities in patients with systemic lupus erythematosus: the role of antiphospholipid antibodies].
Monti M; Borgognoni F; Pastacci L; Vincentelli GM
G Ital Cardiol (Rome); 2016 Dec; 17(12):1001-1007. PubMed ID: 28151504
[TBL] [Abstract][Full Text] [Related]
18. Childhood-onset systemic lupus erythematosus: antiphospholipid antibodies in 37 patients and their first-degree relatives.
Molta C; Meyer O; Dosquet C; Montes de Oca M; Babron MC; Danon F; Kaplan C; Clémenceau S; Castellano F; Levy M
Pediatrics; 1993 Dec; 92(6):849-53. PubMed ID: 8233748
[TBL] [Abstract][Full Text] [Related]
19. Antiphospholipid Antibodies and Autoimmune Haemolytic Anaemia: A Systematic Review and Meta-Analysis.
Ames PRJ; Merashli M; Bucci T; Pastori D; Pignatelli P; Arcaro A; Gentile F
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32527000
[TBL] [Abstract][Full Text] [Related]
20. [Significance of antiphospholipid syndrome and antiphospholipid antibodies in patients with systemic lupus erythematosus in estimation of risk of subclinical atherosclerosis development].
Fischer K; Brzosko M; Walecka A; Ostanek L; Sawicki M
Pol Arch Med Wewn; 2007; 117 Suppl():13-7. PubMed ID: 18778013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
